Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gender-related safety and efficacy of cardiac resynchronization therapy.
Schuchert A, Muto C, Maounis T, Frank R, Ella RO, Polauck A, Padeletti L; MASCOT Study Group. Schuchert A, et al. Among authors: padeletti l. Clin Cardiol. 2013 Nov;36(11):683-90. doi: 10.1002/clc.22203. Epub 2013 Sep 17. Clin Cardiol. 2013. PMID: 24105909 Free PMC article. Clinical Trial.
Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L; MASCOT study group. Schuchert A, et al. Among authors: padeletti l. Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26. Europace. 2013. PMID: 22927665 Clinical Trial.
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group. Padeletti L, et al. Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7. Am Heart J. 2008. PMID: 18760135 Clinical Trial.
Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial.
Brugada J, Brachmann J, Delnoy PP, Padeletti L, Reynolds D, Ritter P, Borri-Brunetto A, Singh JP. Brugada J, et al. Among authors: padeletti l. Am Heart J. 2014 Apr;167(4):429-36. doi: 10.1016/j.ahj.2013.12.007. Epub 2013 Dec 19. Am Heart J. 2014. PMID: 24655689 Free article. Review.
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial.
Brugada J, Delnoy PP, Brachmann J, Reynolds D, Padeletti L, Noelker G, Kantipudi C, Rubin Lopez JM, Dichtl W, Borri-Brunetto A, Verhees L, Ritter P, Singh JP; RESPOND CRT Investigators. Brugada J, et al. Among authors: padeletti l. Eur Heart J. 2017 Mar 7;38(10):730-738. doi: 10.1093/eurheartj/ehw526. Eur Heart J. 2017. PMID: 27941020 Free PMC article. Clinical Trial.
Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.
Leclercq C, Padeletti L, Cihák R, Ritter P, Milasinovic G, Gras D, Paul V, Van Gelder IC, Stellbrink C, Rieger G, Corbucci G, Albers B, Daubert JC; CHAMP Study Investigators. Leclercq C, et al. Among authors: padeletti l. Europace. 2010 Jan;12(1):71-7. doi: 10.1093/europace/eup318. Europace. 2010. PMID: 19864311 Clinical Trial.
379 results